Alex Morgan

Partner

2020 - Current

Investments include: Pardes Bio, Synchron, Atman, Nabla, Carver Biotech, Pearl Bio, Loyal, NextVivo, Robin Health, Relation Therapeutics, Rubedo, Menten.AI, Advanced Chemotherapy Technologies, Invoy, Ochre Bio, Known Medicine, STIMIT, Earli, Turn Biotech, Quadrant Eye, Kilobaser, Kernel, Fountain Biotherapeutics

Principal

2017 - 2020

Investments include: Arpeggio Bio, Atrendex, BioAge, Bionaut, Cellino, Deep Genomics, DiscernDx, Docbot, Ellipsis, Encellin, Faeth, Flow Neuroscience, Hello Heart, Karius, Karma Technologies, Loop Genomics, Mirvie, Nebula Genomics, Oncobox, Overture, Prellis, Probably Genetic, Q Bio, Rejuvenation Technologies, StimScience, Syllable Corporation, Vitro Labs.

Scientist in Residence

2015 - 2017

Helping to create and grow great companies.

Postdoctoral Fellow

2011 - 2012

Co-Founder & Chief Scientist

2009 - 2011

Clinic Manager, IT and Specialty Clinics Coordinator

2007 - 2009

I co-managed this Stanford volunteer staffed weekly free clinic. I also helped customize and deploy the electronic medical record system across the Stanford free clinic sites.

Senior Artificial Intelligence Engineer

2000 - 2006

NLP work on a wide range of research federally funded research projects, including projects for DARPA, Air Force, and Navy. Initiated and received competitive internal research funding for a range of biomedical projects, including work on biomedical text mining, medical record anonymization, epidemic modeling and tracking, and infectious organism bioinformatics.

Lab Instructor: Basic Analog & Digital Electronics

1999 - 2001

Lab Instructor for Introductory Physics and Consultant on Curriculum Development

1998 - 2001

Undergraduate Teaching Assistant

1995 - 1997

Research Assistant

1999 - 1999

Vice President & Chief Financial Officer

1998 - 1998

Research Technician

1997 - 1997